FindTrial
Sign In

Comparison of the recovery quality of intravenous anesthesia with remidazolam or propofol in elder people: a randomized, non-inferiority study

Comparison of the recovery quality of intravenous anesthesia with remidazolam or propofol in elder people: a randomized, non-inferiority study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077199
Enrollment
Unknown
Registered
2023-11-01
Start date
2023-11-01
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine pathology

Interventions

Propofol Group(P Group):Continuous intravenous infusion of propofol to maintain anesthesia.
Remimazolam Group(R Group):Continuous intravenous infusion of remimazolam to maintain anesthesia.

Sponsors

Jinan maternal and child health care hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing laparoscopic total hysterectomy under general anesthesia; 2. ASA I - III; 3. Age = 60years old.

Exclusion criteria

Exclusion criteria: 1. History of allergies to remimazolam or propofol; 2. Currently using sedative opioid drugs or sleep aids; 3. Alcohol dependence; 4. Mental or neurological disorders; 5. Illiteracy; 6. BMI>30 kg/m²; 7. The patient refuses.

Design outcomes

Primary

MeasureTime frame
QoR15 Scale;—

Secondary

MeasureTime frame
dosage of propofol, remimazolam, and remifentanil;hemodynamic data;bispectral index(BIS);Richmond agitation and sedation scale(RASS) ;lost of consciousness(LOC);recovery of consciousness(ROC);incidence rate of nausea/vomiting;complication;—

Countries

China

Contacts

Public ContactFanqing Meng

Jinan maternal and child health care hospital

mengfanqing8211@126.com+86 180 5315 3019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026